BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cappellacci F, Canu GL, Lai ML, Lori E, Biancu M, Boi F, Medas F. Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience. Front Oncol 2022;12:959595. [DOI: 10.3389/fonc.2022.959595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Shi W, Dong F, Wang X, Lu C, Liu C. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021. Front Endocrinol 2023;13. [DOI: 10.3389/fendo.2022.1098204] [Reference Citation Analysis]
2 Tan H, Nyarko A, Duan S, Zhao Y, Chen P, He Q, Zhang Z, Chang S, Huang P. Comprehensive analysis of the effect of Hashimoto’s thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer. Front Endocrinol 2023;13. [DOI: 10.3389/fendo.2022.987906] [Reference Citation Analysis]
3 Mao L, Zheng C, Ou S, He Y, Liao C, Deng G. Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules. Front Endocrinol (Lausanne) 2022;13:1067390. [PMID: 36619577 DOI: 10.3389/fendo.2022.1067390] [Reference Citation Analysis]
4 Shen K, Xiao S, Wu X, Zhang G. Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics. Front Endocrinol 2022;13:1025739. [DOI: 10.3389/fendo.2022.1025739] [Reference Citation Analysis]